Suppr超能文献

线粒体心肌病的分子遗传学研究进展

Progress in Molecular Genetic Study of Mitochondrial Cardiomyopathy.

作者信息

Zhuge Ruiqi, Zhou Rong, Ni Xinhai

机构信息

National Center for Cardiovascular Disease,Department of Cardiology,Fuwai Hospital,CAMS and PUMC,Beijing 100037,China.

出版信息

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Jun 20;39(3):438-444. doi: 10.3881/j.issn.1000-503X.2017.03.024.

Abstract

Mitochondria plays a key role in providing ATP for the energy-consuming cardiac tissues. Mitochondrial cardiomyopathy is a myocardial condition characterized by abnormal heart structure and/or function secondary to genetic defects involving the mitochondrial respiratory chain. The typical cardiac manifestations of mitochondrial cardiomyopathy include hypertrophic and dilated cardiomyopathy,while left ventricular myocardial noncompaction is less common. Recent research has suggested that most mitochondrial diseases result from mitochondrial DNA mutation,which can be found in genes that encode ancillary proteins needed for genetic transcription (tRNA),in genes that encode subunits of the electron transport chain complexes,or in genes that control the activities of the mitochondria called D-loop zone. However,the exact physiological mechanisms remain unclear. This review summarizes the recent advances in the molecular mechanism of mitochondrial cardiomyopathy.

摘要

线粒体在为耗能的心脏组织提供三磷酸腺苷(ATP)方面发挥着关键作用。线粒体心肌病是一种心肌疾病,其特征是继发于涉及线粒体呼吸链的遗传缺陷的心脏结构和/或功能异常。线粒体心肌病的典型心脏表现包括肥厚型和扩张型心肌病,而左心室心肌致密化不全则较少见。最近的研究表明,大多数线粒体疾病是由线粒体DNA突变引起的,这些突变可在编码基因转录所需辅助蛋白(tRNA)的基因中、编码电子传递链复合物亚基的基因中或控制线粒体活性的称为D环区的基因中发现。然而,确切的生理机制仍不清楚。本文综述了线粒体心肌病分子机制的最新研究进展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验